Published Date: 17 Mar 2023
UK: A recent study published in BMJ Medicine found that more caffeine in the blood can reduce the risk of type 2 diabetes and obesity. more...
Read Full NewsBy analyzing data from three clinical trials treating children with the brain tumor medulloblastoma, scientists at St. Jude Children's Research Hospital have designed an approach to safely reduce therapy, thereby lowering ...
Radiotherapy can be safely omitted as a treatment for many breast cancer patients who have had a mastectomy and are taking anti-cancer drugs, a study shows.
People diagnosed with advanced breast cancer in 2025 can expect to live for an extra six or seven months, compared to the average survival time for patients diagnosed in 2011, according to a major study of patient data in ...
1.
Advanced imaging, targeted therapy help men with prostate cancer safely defer surgery and radiation therapy
2.
The Truth About Apple AirPods
3.
Prior authorizations draining time, energy from many cancer patients
4.
Study finds 81% of cancer cures touted by TikTok videos are fake
5.
For patients with clear cell renal cell carcinoma, a new PET agent allows for same-day imaging.
1.
Unlocking the Potential of Lutathera: A Revolutionary Cancer Treatment
2.
Omitting Axillary Dissection in Node-Positive Breast Cancer: Insights from the SENOMAC Trial
3.
How Cancer Cells Evade Immune Destruction and the Fight Back
4.
Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine
5.
Breast Cancer Secrets: AI-Powered Precision Medicine
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
2.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
3.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation